Menu Search
Equities

Nolato AB

NBF:DUS

Nolato AB

Actions
  • Price (EUR)4.54
  • Today's Change0.098 / 2.21%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nolato AB is a Sweden-based company engaged in the development and manufacture of polymer product systems for customers in medical technology, pharmaceuticals, consumer electronics, telecom, automotive products, hygiene and other industrial sectors. The Company’s operations are divided into three operating segments. The Medical Solutions segment develops and manufactures complex product systems and components for medical devices, the pharmaceutical industry and diagnostics. The Integrated Solutions segments offers a wide range of technologies and expertise in a one-stop shop for areas including injection molding, casting, die-cutting, painting, decoration, assembly, testing and packaging of electronic products. The Industrial Solutionssegment develops and manufactures components and product systems for customers in the automotive industry, hygiene, packaging, gardening/ forestry, domestic appliances, furniture and other selected industrial segments. The Company operates worldwide.

  • Revenue in SEK (TTM)9.53bn
  • Net income in SEK570.00m
  • Incorporated1961
  • Employees5.77k
  • Location
    Nolato ABNolatovagen 32, Torekov 269 78SwedenSWE
  • Phone+46 431442290
  • Fax+46 431442291
  • Websitehttps://www.nolato.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.